Prevenotics Inc.

Prevenotics is a pioneering healthcare technology company dedicated to transforming cancer diagnostics and prevention through comprehensive AI-driven solutions. Our flagship product, Prevenotics G Pro, is designed to diagnose pre-cancerous conditions and follow up with targeted responses, aiming to end cancer before it fully develops. Currently focused on gastric cancer, we are expanding our expertise to cover esophageal and colon cancers. Our mission is to provide integrated solutions that detect cancer at its earliest stages, enabling timely intervention and significantly improving patient outcomes. By leveraging advanced AI algorithms, Prevenotics G Pro offers unparalleled accuracy in diagnostic imaging and data analysis, ensuring early detection and effective management of pre-cancer and cancer conditions. We collaborate with leading medical professionals and institutions to constantly refine our technologies and expand our scope. Our commitment to innovation and patient care drives us to create accessible, practical tools for everyday medical use, empowering healthcare providers to deliver the best possible outcomes for their patients.